Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies

Rapid eye movement sleep behavior disorder (RBD) is a prodromal synucleinopathy, as >80% will eventually convert to overt synucleinopathy. We performed an in‐depth analysis of the SNCA locus to identify RBD‐specific risk variants.

[1]  Sonja W. Scholz,et al.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.

[2]  A. Desautels,et al.  Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies , 2019, Annals of neurology.

[3]  W. Rowell,et al.  The Landscape of SNCA Transcripts Across Synucleinopathies: New Insights From Long Reads Sequencing Analysis , 2019, Frontiers in genetics.

[4]  Dawn M. Toolan,et al.  Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease , 2019, Human molecular genetics.

[5]  Yves Dauvilliers,et al.  REM sleep behaviour disorder , 2018, Nature Reviews Disease Primers.

[6]  W. Oertel,et al.  LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. , 2018, Parkinsonism & related disorders.

[7]  M. Nalls,et al.  A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease , 2018, Annals of neurology.

[8]  A. Desautels,et al.  Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder , 2018, Movement disorders : official journal of the Movement Disorder Society.

[9]  E. Dietrichs,et al.  Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study , 2018, BMC Neurology.

[10]  Birgit Frauscher,et al.  Prevalence and determinants of rapid eye movement sleep behavior disorder in the general population , 2018, Sleep.

[11]  Sonja W. Scholz,et al.  Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study , 2018, The Lancet Neurology.

[12]  J. Santamaria,et al.  Idiopathic REM sleep behavior disorder in the elderly Spanish community: a primary care center study with a two-stage design using video-polysomnography. , 2017, Sleep medicine.

[13]  M. Nalls,et al.  A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci , 2017, Nature Genetics.

[14]  Alan J. Thomas,et al.  Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.

[15]  A. Desautels,et al.  The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder , 2017, Neurobiology of Aging.

[16]  Daniela Berg,et al.  Advances in markers of prodromal Parkinson disease , 2016, Nature Reviews Neurology.

[17]  Sonja W. Scholz,et al.  A genome-wide association study in multiple system atrophy , 2016, Neurology.

[18]  Y. Dauvilliers,et al.  Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease , 2016, Neurobiology of Aging.

[19]  Ekaterina Nosova,et al.  α‐synuclein genetic variability: A biomarker for dementia in Parkinson disease , 2016, Annals of neurology.

[20]  Yonatan Stelzer,et al.  Parkinson-associated risk variant in enhancer element produces subtle effect on target gene expression , 2016, Nature.

[21]  Joan Santamaria,et al.  Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions , 2016, The Lancet Neurology.

[22]  E. Tolosa,et al.  Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder , 2016, Neurology.

[23]  Michelle K. Lupton,et al.  Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases , 2016, Neurobiology of Aging.

[24]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[25]  A. Roses,et al.  A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression , 2015, Alzheimer's & Dementia.

[26]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[27]  Jean-François Gagnon,et al.  New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.

[28]  A. Desautels,et al.  GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder , 2015, Annals of clinical and translational neurology.

[29]  G. Halliday,et al.  Alpha-synuclein biology in Lewy body diseases , 2014, Alzheimer's Research & Therapy.

[30]  A. Roses,et al.  The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease. , 2014, Human molecular genetics.

[31]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[32]  Catherine Boileau,et al.  Cohort profile of the CARTaGENE study: Quebec's population-based biobank for public health and personalized genomics. , 2013, International journal of epidemiology.

[33]  Carlos H Schenck,et al.  Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. , 2013, Sleep medicine.

[34]  T. Kim,et al.  REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. , 2013, Sleep.

[35]  J. Molinuevo,et al.  Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study , 2013, The Lancet Neurology.

[36]  Xihong Lin,et al.  Optimal tests for rare variant effects in sequencing association studies. , 2012, Biostatistics.

[37]  Poul Jennum,et al.  A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study , 2012, Movement disorders : official journal of the Movement Disorder Society.

[38]  R. Postuma,et al.  Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study , 2012, Movement disorders : official journal of the Movement Disorder Society.

[39]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[40]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[41]  Yuichi Inoue,et al.  Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients. , 2011, Sleep medicine.

[42]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[43]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[44]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[45]  K. Marder,et al.  Association of glucocerebrosidase mutations with dementia with lewy bodies. , 2009, Archives of neurology.

[46]  M. Vendette,et al.  Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder , 2009, Neurology.

[47]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[48]  J. Doyon,et al.  REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia , 2007, Neurology.

[49]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[50]  D J Brooks,et al.  DLB and PDD boundary issues , 2007, Neurology.

[51]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[52]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[53]  M. Thorpy.  Classification of Sleep Disorders , 1990, Neurotherapeutics.

[54]  Ambra Stefani,et al.  Idiopathic REM sleep behaviour disorder and neurodegeneration — an update , 2018, Nature Reviews Neurology.

[55]  D. Clayton,et al.  A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. , 2002, American journal of human genetics.